Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Paul Strauss

About this trial

Standard Magnetic Resonance Imaging (MRI) is based on the excitation of hydrogen nuclei that are presents in water molecules, which abundance in human body allows for obtention of superior contrast. However, assessing the presence of other molecules than water in tissues is also of great clinical interest to probe metabolites related to physiological body function and pathological conditions.

Chemical exchange saturation transfer (CEST) allow to overcome some limitations of proton magnetic resonance spectroscopy (1H-MRS) by exploiting chemical properties of the targeted molecule through a continuous process of re-saturation and exchange, and thus detecting it with increased sensitivity, from two orders of magnitude. Moreover, CEST technique is based on imaging sequences and can therefore benefit from well-known fast acquisition strategies, as well as improved spatial resolution.

Eligibility criteria

Qualifiers

Preoperative evaluation of a cerebral expansion lesion

Evaluation of glioma recurrences

Evaluation of brain metastases

Evaluation of recurrence of metastases

Disqualifiers

Contraindication to the realization of an MRI

Minor or patients placed under guardianship or supervision

Patients deprived of liberty

Patients placed under judicial protection

Trial design

Treatments tested in this trial

  • Additional CEST sequences during PET/MRI exam

Treatment groups

800 Participants
are divided into 1 treatment group

Sponsors and collaborators